Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The influence of dexamethasone administration on the protection against doxorubicin-induced cardiotoxicity in purified embryonic stem cell-derived cardiomyocytes.

Dehghani L, Farokhpour M, Karbalaie K, Nematollahi M, Tanhaie S, Hayati-Rodbari N, Kiani-Esfahani A, Hescheler J, Nasr-Esfahani MH, Baharvand H.

Tissue Cell. 2013 Apr;45(2):101-6. doi: 10.1016/j.tice.2012.09.009. Epub 2012 Nov 9.

PMID:
23141520
2.

Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity.

Farokhpour M, Karbalaie K, Tanhaei S, Nematollahi M, Etebari M, Sadeghi HM, Nasr-Esfahani MH, Baharvand H.

Toxicol In Vitro. 2009 Oct;23(7):1422-8. doi: 10.1016/j.tiv.2009.07.008. Epub 2009 Jul 22.

PMID:
19596060
3.

Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells.

Hatami L, Valojerdi MR, Mowla SJ.

Int J Cardiol. 2007 Apr 12;117(1):80-9. Epub 2006 Oct 10.

PMID:
17034884
4.

Bone marrow stromal cells as an inducer for cardiomyocyte differentiation from mouse embryonic stem cells.

Yue F, Johkura K, Tomotsune D, Shirasawa S, Yokoyama T, Nagai M, Sasaki K.

Ann Anat. 2010 Sep 20;192(5):314-21. doi: 10.1016/j.aanat.2010.07.001. Epub 2010 Aug 5.

PMID:
20801009
5.

Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA.

Sun M, Yan X, Bian Y, Caggiano AO, Morgan JP.

Am J Physiol Cell Physiol. 2011 Jul;301(1):C21-30. doi: 10.1152/ajpcell.00141.2010. Epub 2011 Mar 30.

6.

Electrophysiological characteristics of embryonic stem cell-derived cardiomyocytes are cell line-dependent.

Hannes T, Wolff M, Doss MX, Pfannkuche K, Haustein M, Müller-Ehmsen J, Sachinidis A, Hescheler J, Khalil M, Halbach M.

Cell Physiol Biochem. 2015;35(1):305-14. doi: 10.1159/000369697. Epub 2015 Jan 10.

7.

Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells.

Singh AM, Li FQ, Hamazaki T, Kasahara H, Takemaru K, Terada N.

Circulation. 2007 Feb 6;115(5):617-26. Epub 2007 Jan 29.

8.

Neuregulin-1 promotes cardiomyocyte differentiation of genetically engineered embryonic stem cell clones.

Wang Z, Xu G, Wu Y, Liu S, Sun B, Dai Q.

BMB Rep. 2008 Oct 31;41(10):699-704.

PMID:
18959815
9.

A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.

Shinozawa T, Furukawa H, Sato E, Takami K.

J Biomol Screen. 2012 Jun;17(5):683-91. doi: 10.1177/1087057111434145. Epub 2012 Jan 24.

PMID:
22274911
10.

[Expression profile of microRNAs in the cardiomyocytes derived from mouse embryonic stem cells].

Chen F, Chen ZY, Yang HT.

Sheng Li Xue Bao. 2014 Dec 25;66(6):702-8. Chinese.

11.

Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.

Guenancia C, Li N, Hachet O, Rigal E, Cottin Y, Dutartre P, Rochette L, Vergely C.

Toxicol Appl Pharmacol. 2015 Apr 15;284(2):152-62. doi: 10.1016/j.taap.2015.02.015. Epub 2015 Feb 21.

PMID:
25711856
12.

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi ME.

Stem Cells. 2007 May;25(5):1136-44. Epub 2007 Jan 25.

13.
14.

Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice.

Bruynzeel AM, Abou El Hassan MA, Schalkwijk C, Berkhof J, Bast A, Niessen HW, van der Vijgh WJ.

Br J Cancer. 2007 Mar 26;96(6):937-43. Epub 2007 Feb 27.

15.

Exogenous treatment with eicosapentaenoic acid supports maturation of cardiomyocytes derived from embryonic stem cells.

Shabani P, Ghazizadeh Z, Pahlavan S, Hashemizadeh S, Baharvand H, Aghdami N, Doosti M.

Biochem Biophys Res Commun. 2015 May 29;461(2):281-6. doi: 10.1016/j.bbrc.2015.04.018. Epub 2015 Apr 12.

PMID:
25871791
16.

The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.

Bruynzeel AM, Mul PP, Berkhof J, Bast A, Niessen HW, van der Vijgh WJ.

Cancer Chemother Pharmacol. 2006 Nov;58(5):699-702. Epub 2006 Mar 25.

PMID:
16565833
17.

Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway.

Lee YK, Ng KM, Chan YC, Lai WH, Au KW, Ho CY, Wong LY, Lau CP, Tse HF, Siu CW.

Mol Endocrinol. 2010 Sep;24(9):1728-36. doi: 10.1210/me.2010-0032. Epub 2010 Jul 28.

PMID:
20667986
18.

Effect of basic fibroblast growth factor on cardiomyocyte differentiation from mouse embryonic stem cells.

Khezri S, Valojerdi MR, Sepehri H, Baharvand H.

Saudi Med J. 2007 Feb;28(2):181-6.

PMID:
17268693
19.

Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes.

Shafa M, Krawetz R, Zhang Y, Rattner JB, Godollei A, Duff HJ, Rancourt DE.

BMC Cell Biol. 2011 Dec 14;12:53. doi: 10.1186/1471-2121-12-53.

20.

Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.

Li K, Sung RY, Huang WZ, Yang M, Pong NH, Lee SM, Chan WY, Zhao H, To MY, Fok TF, Li CK, Wong YO, Ng PC.

Circulation. 2006 May 9;113(18):2211-20. Epub 2006 May 1.

Items per page

Supplemental Content

Write to the Help Desk